Analyst Price Target is $110.43
▲ +8.74% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Globe Life in the last 3 months. The average price target is $110.43, with a high forecast of $130.00 and a low forecast of $85.00. The average price target represents a 8.74% upside from the last price of $101.55.
Current Consensus is
Hold
The current consensus among 6 polled investment analysts is to hold stock in Globe Life. This rating has held steady since January 2022, when it changed from a Buy consensus rating.
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Read More